Lv4
560 积分 2025-07-07 加入
Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential
5个月前
已完结
Antibody–Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release
8个月前
已完结
CBP-1018, A DUAL-LIGAND DRUG TARGETING PSMA-FOLR1, IS AVAILABLE FOR PROSTATE CANCER TREATMENT AND HAS THE POTENTIAL TO BE USED IN COMBINATION WITH OTHER THERAPIES
8个月前
已关闭
CBP-1018, A DUAL-LIGAND DRUG TARGETING PSMA-FOLR1, IS AVAILABLE FOR PROSTATE CANCER TREATMENT AND HAS THE POTENTIAL TO BE USED IN COMBINATION WITH OTHER THERAPIES
8个月前
已关闭
Abstract 6249: CBX-12: A low pH targeting alphalex™-exatecan conjugate for the treatment of solid tumors
8个月前
已关闭
Zelenectide pevedotin (BT-8009): a bicyclic peptide toxin conjugate targeting nectin-4 for the treatment of bladder cancer
8个月前
已完结
Abstract 1061: Increasing potency of anticancer drugs through Sortilin receptor-mediated cancer therapy: A new targeted approach for the treatment of ovarian cancer
8个月前
已关闭
Abstract 1061: Increasing potency of anticancer drugs through Sortilin receptor-mediated cancer therapy: A new targeted approach for the treatment of ovarian cancer
8个月前
已关闭
Abstract 5144: BT1718, a novel bicyclic peptide-maytansinoid conjugate targeting MT1-MMP for the treatment of solid tumors: Design of bicyclic peptide and linker selection
8个月前
已完结
皖公网安备34019202002308
